45 CFR § 180 compliance
B · 85
This hospital published most of what § 180 requires.
●Machine-readable file published: assessment threshold met
●Gross / standard charges: assessment threshold met
●Discounted cash price: assessment threshold met
●Payer-specific negotiated rates: assessment threshold met
○Min / max negotiated charges: below assessment threshold
●Free, public, no login required: assessment threshold met
Procedures listed
147,911
Insurances with rates
19
CPT / HCPCS codes
0
Most expensive procedures (gross)
1013136
$187,706
00944-3810-01 - pegaspargase 750 iu/ml Inj
Gross
$187,706
1013136
$187,706
00944-3810-01 - pegaspargase 750 iu/ml Inj
Gross
$187,706
1337261
$187,706
72694-0954-01 - pegaspargase 750 iu/ml Inj
Gross
$187,706
1337261
$187,706
72694-0954-01 - pegaspargase 750 iu/ml Inj
Gross
$187,706
618650
$187,706
57665-0002-02 - pegaspargase 750 unit/ml Inj 5ml (
Gross
$187,706
618650
$187,706
57665-0002-02 - pegaspargase 750 unit/ml Inj 5ml (
Gross
$187,706
1013136
$187,706
00944-3810-01 - pegaspargase 750 iu/ml Inj
Gross
$187,706
1337261
$187,706
72694-0954-01 - pegaspargase 750 iu/ml Inj
Gross
$187,706
618650
$187,706
57665-0002-02 - pegaspargase 750 unit/ml Inj 5ml (
Gross
$187,706
1274660
$139,245
NAIL TIB ANT 10D 11.5X320X7/8
Gross
$139,245
1274660
$139,245
NAIL TIB ANT 10D 11.5X320X7/8
Gross
$139,245
1330763
$139,245
NAIL TIB ANT 10D 11.5X380X7/8
Gross
$139,245
1330763
$139,245
NAIL TIB ANT 10D 11.5X380X7/8
Gross
$139,245
1274660
$139,245
NAIL TIB ANT 10D 11.5X320X7/8
Gross
$139,245
1330763
$139,245
NAIL TIB ANT 10D 11.5X380X7/8
Gross
$139,245
1561290
$122,671
00310-4535-30 - tremelimumab actl 20 mg/mL Sol
Gross
$122,671
1561290
$122,671
00310-4535-30 - tremelimumab actl 20 mg/mL Sol
Gross
$122,671
1561290
$122,671
00310-4535-30 - tremelimumab actl 20 mg/mL Sol
Gross
$122,671
1491080
$115,000
SYSTEM PROCLAIM 1 DRG LEAD
Gross
$115,000
1491080
$115,000
SYSTEM PROCLAIM 1 DRG LEAD
Gross
$115,000
1491080
$115,000
SYSTEM PROCLAIM 1 DRG LEAD
Gross
$115,000
1376701
$111,842
75987-0080-10 - pegloticase 8 mg/mL Inj
Gross
$111,842
1376701
$111,842
75987-0080-10 - pegloticase 8 mg/mL Inj
Gross
$111,842
1376701
$111,842
75987-0080-10 - pegloticase 8 mg/mL Inj
Gross
$111,842
1524278
$111,563
GENERATOR SENTIVA DUO 1000-D
Gross
$111,563
1524278
$111,563
GENERATOR SENTIVA DUO 1000-D
Gross
$111,563
1524278
$111,563
GENERATOR SENTIVA DUO 1000-D
Gross
$111,563
1039504
$108,842
GENERATOR SENTIVA 1000
Gross
$108,842
1039504
$108,842
GENERATOR SENTIVA 1000
Gross
$108,842
1039504
$108,842
GENERATOR SENTIVA 1000
Gross
$108,842
1497723
$106,079
65219-0552-02 - PRALAtrexate 20 mg/mL Sol
Gross
$106,079
1497723
$106,079
65219-0552-02 - PRALAtrexate 20 mg/mL Sol
Gross
$106,079
1502846
$106,079
72893-0005-01 - PRALAtrexate 20 mg/mL Sol
Gross
$106,079
1502846
$106,079
72893-0005-01 - PRALAtrexate 20 mg/mL Sol
Gross
$106,079
1497723
$106,079
65219-0552-02 - PRALAtrexate 20 mg/mL Sol
Gross
$106,079
1502846
$106,079
72893-0005-01 - PRALAtrexate 20 mg/mL Sol
Gross
$106,079
1044195
$104,400
CCLS-CRM-ICD NOT S OR D LVLIII
Gross
$104,400
1044195
$104,400
CCLS-CRM-ICD NOT S OR D LVLIII
Gross
$104,400
1044195
$104,400
CCLS-CRM-ICD NOT S OR D LVLIII
Gross
$104,400
1044194
$104,094
CCLS-CRM-ICD NOT S OR D LVL II
Gross
$104,094
1044194
$104,094
CCLS-CRM-ICD NOT S OR D LVL II
Gross
$104,094
1044194
$104,094
CCLS-CRM-ICD NOT S OR D LVL II
Gross
$104,094
995253
$101,835
GENERATOR ASPIRE SR 106
Gross
$101,835
995253
$101,835
GENERATOR ASPIRE SR 106
Gross
$101,835
1356570
$101,700
NEUROSTIMULATOR RNS
Gross
$101,700
1356570
$101,700
NEUROSTIMULATOR RNS
Gross
$101,700
1371435
$101,700
KIT NEUROSTIMULATOR RNS
Gross
$101,700
1371435
$101,700
KIT NEUROSTIMULATOR RNS
Gross
$101,700
1356570
$101,700
NEUROSTIMULATOR RNS
Gross
$101,700
1371435
$101,700
KIT NEUROSTIMULATOR RNS
Gross
$101,700
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| 1013136 | 00944-3810-01 - pegaspargase 750 iu/ml Inj | $187,706 | $187,706 | — | — | 9 |
| 1013136 | 00944-3810-01 - pegaspargase 750 iu/ml Inj | $187,706 | $187,706 | — | — | 17 |
| 1337261 | 72694-0954-01 - pegaspargase 750 iu/ml Inj | $187,706 | $187,706 | — | — | 9 |
| 1337261 | 72694-0954-01 - pegaspargase 750 iu/ml Inj | $187,706 | $187,706 | — | — | 17 |
| 618650 | 57665-0002-02 - pegaspargase 750 unit/ml Inj 5ml ( | $187,706 | $187,706 | — | — | 9 |
| 618650 | 57665-0002-02 - pegaspargase 750 unit/ml Inj 5ml ( | $187,706 | $187,706 | — | — | 17 |
| 1013136 | 00944-3810-01 - pegaspargase 750 iu/ml Inj | $187,706 | $187,706 | — | — | 1 |
| 1337261 | 72694-0954-01 - pegaspargase 750 iu/ml Inj | $187,706 | $187,706 | — | — | 1 |
| 618650 | 57665-0002-02 - pegaspargase 750 unit/ml Inj 5ml ( | $187,706 | $187,706 | — | — | 1 |
| 1274660 | NAIL TIB ANT 10D 11.5X320X7/8 | $139,245 | $139,245 | — | — | 10 |
| 1274660 | NAIL TIB ANT 10D 11.5X320X7/8 | $139,245 | $139,245 | — | — | 18 |
| 1330763 | NAIL TIB ANT 10D 11.5X380X7/8 | $139,245 | $139,245 | — | — | 10 |
| 1330763 | NAIL TIB ANT 10D 11.5X380X7/8 | $139,245 | $139,245 | — | — | 18 |
| 1274660 | NAIL TIB ANT 10D 11.5X320X7/8 | $139,245 | $139,245 | — | — | 0 |
| 1330763 | NAIL TIB ANT 10D 11.5X380X7/8 | $139,245 | $139,245 | — | — | 0 |
| 1561290 | 00310-4535-30 - tremelimumab actl 20 mg/mL Sol | $122,671 | $122,671 | — | — | 9 |
| 1561290 | 00310-4535-30 - tremelimumab actl 20 mg/mL Sol | $122,671 | $122,671 | — | — | 17 |
| 1561290 | 00310-4535-30 - tremelimumab actl 20 mg/mL Sol | $122,671 | $122,671 | — | — | 1 |
| 1491080 | SYSTEM PROCLAIM 1 DRG LEAD | $115,000 | $115,000 | — | — | 10 |
| 1491080 | SYSTEM PROCLAIM 1 DRG LEAD | $115,000 | $115,000 | — | — | 18 |
| 1491080 | SYSTEM PROCLAIM 1 DRG LEAD | $115,000 | $115,000 | — | — | 0 |
| 1376701 | 75987-0080-10 - pegloticase 8 mg/mL Inj | $111,842 | $111,842 | — | — | 9 |
| 1376701 | 75987-0080-10 - pegloticase 8 mg/mL Inj | $111,842 | $111,842 | — | — | 17 |
| 1376701 | 75987-0080-10 - pegloticase 8 mg/mL Inj | $111,842 | $111,842 | — | — | 1 |
| 1524278 | GENERATOR SENTIVA DUO 1000-D | $111,563 | $111,563 | — | — | 10 |
| 1524278 | GENERATOR SENTIVA DUO 1000-D | $111,563 | $111,563 | — | — | 18 |
| 1524278 | GENERATOR SENTIVA DUO 1000-D | $111,563 | $111,563 | — | — | 0 |
| 1039504 | GENERATOR SENTIVA 1000 | $108,842 | $108,842 | — | — | 10 |
| 1039504 | GENERATOR SENTIVA 1000 | $108,842 | $108,842 | — | — | 18 |
| 1039504 | GENERATOR SENTIVA 1000 | $108,842 | $108,842 | — | — | 0 |
| 1497723 | 65219-0552-02 - PRALAtrexate 20 mg/mL Sol | $106,079 | $106,079 | — | — | 9 |
| 1497723 | 65219-0552-02 - PRALAtrexate 20 mg/mL Sol | $106,079 | $106,079 | — | — | 17 |
| 1502846 | 72893-0005-01 - PRALAtrexate 20 mg/mL Sol | $106,079 | $106,079 | — | — | 9 |
| 1502846 | 72893-0005-01 - PRALAtrexate 20 mg/mL Sol | $106,079 | $106,079 | — | — | 17 |
| 1497723 | 65219-0552-02 - PRALAtrexate 20 mg/mL Sol | $106,079 | $106,079 | — | — | 1 |
| 1502846 | 72893-0005-01 - PRALAtrexate 20 mg/mL Sol | $106,079 | $106,079 | — | — | 1 |
| 1044195 | CCLS-CRM-ICD NOT S OR D LVLIII | $104,400 | $104,400 | — | — | 10 |
| 1044195 | CCLS-CRM-ICD NOT S OR D LVLIII | $104,400 | $104,400 | — | — | 17 |
| 1044195 | CCLS-CRM-ICD NOT S OR D LVLIII | $104,400 | $104,400 | — | — | 0 |
| 1044194 | CCLS-CRM-ICD NOT S OR D LVL II | $104,094 | $104,094 | — | — | 10 |
| 1044194 | CCLS-CRM-ICD NOT S OR D LVL II | $104,094 | $104,094 | — | — | 17 |
| 1044194 | CCLS-CRM-ICD NOT S OR D LVL II | $104,094 | $104,094 | — | — | 0 |
| 995253 | GENERATOR ASPIRE SR 106 | $101,835 | $101,835 | — | — | 10 |
| 995253 | GENERATOR ASPIRE SR 106 | $101,835 | $101,835 | — | — | 18 |
| 1356570 | NEUROSTIMULATOR RNS | $101,700 | $101,700 | — | — | 10 |
| 1356570 | NEUROSTIMULATOR RNS | $101,700 | $101,700 | — | — | 18 |
| 1371435 | KIT NEUROSTIMULATOR RNS | $101,700 | $101,700 | — | — | 10 |
| 1371435 | KIT NEUROSTIMULATOR RNS | $101,700 | $101,700 | — | — | 18 |
| 1356570 | NEUROSTIMULATOR RNS | $101,700 | $101,700 | — | — | 0 |
| 1371435 | KIT NEUROSTIMULATOR RNS | $101,700 | $101,700 | — | — | 0 |
Showing top 50 of 147,911 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.